- 大会
- 英卡思亚洲年会 - 2025年 6月
- 英卡思中国大会 - 2025年 7月
- 英卡思巴黎国际年会 - 2026年 1月
- 大师精品课
- 英卡思印度大会 - 2025年 11月
- 大会
- 英卡思亚洲年会 - 2025年 6月
- 英卡思中国大会 - 2025年 7月
- 英卡思巴黎国际年会 - 2026年 1月
- 大师精品课
- 英卡思印度大会 - 2025年 11月

英卡思学院

注册新账号

介绍
大会日程
讲者
赞助企业名单
大会地图
认证

回到上页

2025 英卡思巴黎国际年会
大会日程

针对您所在时区的直播课程/会议的时间

时区参照: (UTC+02:00) Europe, Paris

时区

时区:改换时区

If you are logged in, change your default time zone in your account

Open Stage - Non-sponsored scientific lectures

会议室： Open stage (Exh.hall) - Level 3
日期： 2025年 2月 1日星期六从 08:30 至 10:30
组织形式： 开放式舞台演讲 > 在展区内的专用舞台上录制口头演讲

本场演讲内容

小时	讲者	演讲标题	讲稿摘要	数字
08:30	Aleksandar JOSIPOVIC	Transformative Marketing Strategies for Pseudoxanthoma Elasticum: A Case Study on Innovative Campaigns	查看	142831
08:40	Zaid AL SAMKARI 医师	AI Integration in Aesthetic Medicine	查看	140655
08:50	Tammy Bellerlin TORIBIO RIVERA 医师	Aesthetic Approach of the Oncological Patient	查看	140656
09:00	Ashley MOORES	How to be the best practitioner	查看	142821
09:10	Nadia YOUSRI 医师	Clitoxin (Neurotoxin injection) for enhancing women’s orgasmic cycle - Case presentation	查看	140659
09:20	Mykola BOIKO 医师	Male androgenetic alopecia and Post‐Finasteride Syndrome	查看	142832
09:30	Fernanda MONTORIL OLIVEIRA 医师	The Use of Poly-L-Lactic Acid and the Enhancement of Its Effects through Intramuscular Proline, L-Lysine, D-Panthenol, and Biotin	查看	140660
09:40	Alfredo MARTINEZ 医师	The future of HA fillers: innovative delivery system beyond cross-linking	查看	142830
09:50	Juliah Ahmad TBARANI 医师	Non surgical Rhinoplasties - Is cannula safer than needle?	查看	140658
10:00	Jyoti ANEJA 医师	The Sherlockian Approach to Neck Rejuvenation in the Regenerative Aesthetics Era	查看	142833
10:10	Raul ANTUNEZ CONDE HIDALGO 医师	OROFACIAL AESTHETICS IN THE ONCOLOGIC PATIENT: A PROSPECTIVE STUDY FOR RECONSTRUCTION AND PROSTHETIC REHABILITATION	查看	140657
10:20	Rebecca Susanna DEGLIUOMINI 医师	Botulinum Toxin and Radiofrequency for the Treatment of Vaginismus and Dyspareunia: A Combined Protocol	查看	142820

上一个会议室 (Lunch Stations)

进入下一场会议

推荐会议

联合疗法

数字通信与社交媒体

女性私密整形（非手术）

抗衰老

患者沟通与心理

Aleksandar JOSIPOVIC

营销专家

摩纳哥

其他作者 : Aleksandar Josipovic

Transformative Marketing Strategies for Pseudoxanthoma Elasticum: A Case Study on Innovative Campaigns

Objectives: Objectives:

- Understand the unique challenges and considerations in marketing treatments for Pseudoxanthoma Elasticum (PXE).
- Explore innovative marketing strategies and their application to rare skin conditions.
- Analyze the success metrics and outcomes of the PXE campaign.
- Gain insights into developing patient-centric marketing campaigns for dermatological treatments.
- Learn to navigate regulatory constraints while effectively promoting advanced treatment options.

Introduction: Pseudoxanthoma Elasticum (PXE) is a rare genetic disorder that affects the skin, eyes, and cardiovascular system, presenting unique challenges for effective treatment marketing. This lecture explores a groundbreaking campaign designed to raise awareness and promote innovative treatment solutions for PXE. By delving into strategic approaches and patient-centric methods, we aim to provide valuable insights into overcoming obstacles and achieving impactful results in the niche field of rare skin condition marketing.

Materials / method: This section outlines the approach and methodology utilized in the marketing campaign for Pseudoxanthoma Elasticum (PXE). We conducted extensive market research through surveys, focus groups, and interviews with PXE patients and healthcare providers. Educational content was developed, including articles, patient testimonials, and videos. A multi-channel digital marketing strategy was employed, using social media, email marketing, and strategic partnerships to maximize outreach and engagement.

Results: The PXE marketing campaign is designed to deliver significant outcomes. Based on pre-launch activities and market research, we anticipate a strong initial response. Key metrics include projected increases in social media engagement by 50%, a 35% rise in website traffic, and substantial interactions with educational content. We expect patient testimonials to generate a 40% increase in community engagement and support. Early feedback indicates a high level of interest and positive reception, suggesting the campaign will effectively raise awareness, educate patients.

Conclusion: This lecture presents a comprehensive case study on the innovative marketing campaign for Pseudoxanthoma Elasticum (PXE). The campaign’s strategic approach, focusing on patient-centric content and multi-channel engagement, is projected to significantly raise awareness and educate the target audience. Anticipated outcomes include increased digital engagement, community support, and improved patient-provider connections. The success of this campaign will offer valuable insights into effective marketing strategies for rare medical conditions.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。 Aleksandar Josipovic

Zaid AL SAMKARI 医师

美容整型外科医师

约旦

其他作者 :

AI Integration in Aesthetic Medicine

Objectives: • Demonstrate the role of AI in enhancing patient engagement and compliance.
• Explain how AI driven applications can help patients stay on top of their treatment plans through timely notifications and progress tracking.
• Illustrate the impact of 3D Simulation and AI on treatment planning- show how AI powered 3D facial analysis can assist clinicians in accurately diagnosing and planning aesthetic procedures.
• Highlighting the connection between AI tools and improved patient satisfaction.
• Emphasize AI’s contribution to clinical efficiency and success.

Introduction: The integration of AI in aesthetics medicine is transforming the way clinics
deliver care and achieve results. From AI-Powered 3D simulations to
personalized treatment planning, these technologies are helping clinicians
provide more accurate, efficient, and patient centered services. By
improving diagnosis, outcomes, and satisfaction, AI is shaping the future of
cosmetic procedures.

Materials / method: • Infographics and charts to present how AI-driven tracking of progress improve patient compliance. Comparison data between patients using AI APP and those without.
• Demonstration of an AI-driven patient app illustrating how notifications work in real-time to remind patients
• Presenting multiple real-world case studies of patients who benefited from technological tracking that led to better adherence.
• 3D Simulation demonstrated in action showing how it helps in analyzing a patient’s unique anatomy and planning aesthetic procedures
• Surveys, Feedback, interactive tools

Results: Higher satisfaction rate, greater patient involvement, improved retention, more predictable outcome.
The integration of AI and 3D simulation in aesthetic medicine has had a transformative effect on clinical practices. Patients are more engaged, satisfies, and likely to follow through with their treatments. Clinical benefit from increased efficiency, fewer errors, and higher patient retention. Positioning AI as a critical tool in the future of aesthetic medicine. These outcomes reflect success of AI in creating a more patient centered, data driven approach to cosmetic procedures.

Conclusion: AI integration in aesthetic medicine is revolutionizing the field by enhancing treatment precision, patient satisfaction, and clinical efficiency. Its ability to personalize care and streamline operations makes it a vital tool for the future of cosmetic procedures.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Tammy Bellerlin TORIBIO RIVERA 医师

医师

多米尼加共和国

其他作者 : The objective of oncological aesthetic medicine is to prevent, improve and treat totally or partially the unsightly aspects of the cancer patient to benefit their quality of life, providing treatments aimed at preventing and minimizing the side effects of

Aesthetic Approach of the Oncological Patient

Objectives: The objective of oncological aesthetic medicine is to prevent, improve and treat totally or partially the unsightly aspects of the cancer patient to benefit their quality of life, providing treatments aimed at preventing and minimizing the side effects of antineoplastic or surgical treatments of the cancer patients.

Introduction: Cancer is an increasingly common disease. According to WHO data, the number of cases of this pathology grows every year.

Materials / method: A systematic search of the subject was carried out in bibliographic reviews of
medical journals, articles specialized in oncology and bibliographic references of textbooks PubMed, Medline, Scielo, JCAD, RESEARCHGATE, Sciencedirect, in accordance with the PRISMA statement. All searches were performed between January 2018 and April 2024.

Results: The results obtained in this research showed us the efficacy of medical-aesthetic
support in oncology to significantly reduce the anguish and concern of the patient in the face of this disease, improving their recovery; This effect goes beyond improving physical appearance but also these aesthetic treatments favor the patient to maintain a positive state of mind and feel better about himself despite going through a disease as catastrophic.
as cancer.

Conclusion: I recognize that the aesthetic medicine approach in cancer patients is vital to
help improve their recovery process, since cancer therapies cause undesirable side effects on the skin that directly affect patients' self-esteem; For this reason, aesthetic treatments are an indispensable tool that allows us to offer comprehensive care for the aesthetic treatment of the skin supported by complementary therapies for the management of this disease.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Ashley MOORES

执业护士

加拿大

其他作者 :

How to be the best practitioner

Objectives: To define and underscore the importance of integrity in aesthetic practices.
To examine the impact of social media on ethical practices in the aesthetics industry.
To share personal experiences and real-world examples of ethical dilemmas and resolutions.
To provide strategies for resolving ethical dilemmas and maintaining professional integrity.

Introduction: This presentation explores the critical importance of maintaining integrity within the field of aesthetics. Integrity, defined as adherence to moral and ethical principles, serves as the cornerstone for professional code and conduct, and client trust in aesthetic practices. The foundation of ethical standards in aesthetics involves a commitment to honesty, transparency, and the prioritization of client safety and well-being.

Materials / method: The role of social media in the aesthetics industry will be examined, highlighting both the benefits and potential risks associated with prioritizing trends over ethical practices. Personal experiences will be shared to illustrate how social media can sometimes promote unsafe practices and unrealistic beauty standards, leading to ethical dilemmas. Real-world examples will be presented to demonstrate how to navigate these challenges effectively.

Results: The analysis of social media’s impact will provide insights into common ethical dilemmas in the aesthetics industry. The discussion will reveal how social media can influence practitioner behavior and client expectations, sometimes at the expense of ethical standards and client safety. The real-world examples provided will showcase successful strategies for maintaining integrity and client trust in the face of these challenges.

Conclusion: This presentation underscores the necessity of continuous education, self-reflection, and a steadfast commitment to professional integrity in the aesthetics industry. It aims to equip aesthetic practitioners with the knowledge and tools necessary to uphold ethical standards, foster client trust, and ensure safe and responsible practice in an increasingly trend-driven industry. By adhering to these principles, practitioners can navigate the complexities of modern aesthetics while maintaining the highest standards of ethical conduct.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Nadia YOUSRI 医师

医师

英国

其他作者 :

Clitoxin (Neurotoxin injection) for enhancing women’s orgasmic cycle - Case presentation

Objectives: -Review on the current the FDA approved options for treatment of female Sexual Dysfunctions.
-Review on the possible mechanism of Neurotoxin injection in improving the whole sexual cycle elements (in the light of the RCT of Use of Neurotoxin in Male Erectile Dysfunction cases)
-Technique & dose
-Case presentations

Introduction: Reduced libido & hypo-orgasmic disorders (HSD) are under reported & under treated problem in women of all age group
The available FDA approved options are not entirely satisfactory to address the various elements or sequence of the female sexual as such
Hence the need to look for a new modality that could be comprehensive and effective
The idea of the use of Neurotoxin to improve the blood flow in the feminine area is based on the same idea of Neurotoxin injection for treatment of Male Erectile Dysfunction that was proved effective in the RCT.

Materials / method: -Review on the current the FDA approved options for treatment of female Sexual Dysfunctions.
-Review on the possible mechanism of Neurotoxin injection in improving the whole sexual cycle elements (in the light of the RCT of Use of Neurotoxin in Male Erectile Dysfunction cases)
-Technique & dose

Results: -Case presentations with case selection for evaluating the procedure over 6 months period

Conclusion: Neurotoxin injection could be a good option to enhance the female sexual cycle

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Mykola BOIKO 医师

泌尿科医师

乌克兰

其他作者 :

Male androgenetic alopecia and Post‐Finasteride Syndrome

Objectives: The hair cycle and hair follicle structure are highly affected by various hormones. Androgens-such as testosterone(T), dihydrotestosterone(DHT), and their prohormones - are the key factors in terminal hair growth. They bind to intracellular androgen receptors in the dermal papilla cells of the hair follicle. The majority of hair follicles also require the intracellular enzyme 5-alpha reductase to convert T into DHT.

Introduction: Androgenetic alopecia (AGA) is the most common form of hair loss consisting of a characteristic receding frontal hairline. Although a variety of medical, surgical, light-based and nutraceutical treatment options , it can be challenging to select appropriate therapies for this chronic condition.The literature has shown finasteride to be effective in treating patients with AGA and long‐term use of up to 5 years has shown significant hair growth and permanent stabilization of hair loss.

Materials / method: Finasteride and dutasteride can trigger an enduring sexual dysfunction that persisted even after stopping treatment. This includes erectile dysfunction, libido disorders, ejaculation disorders and orgasm disorders that continued after discontinuation of finasteride. Additional finasteride effects that can occur independently of any sexual difficulties but may also accompany sexual problems include: cognitive impairment depression, suicidality.

Results: Due to the risk of sexual side effects, clinicians should exercise caution when treating AGA patients with finasteride. The International Post‐Finasteride Syndrome(PFS) Foundation was established to provide public education and support for those patients living with PFS. The World Health Organization Programme for International Drug Monitoring’s database currently contains 21 274 finasteride adverse drug reaction, including 3725 reports of erectile dysfunction, 5204 reports of psychiatric disorders. Additionally, the database currently contains 103 cases of completed suicide.

Conclusion: The report discusses possible mechanisms of PFS development, including the nocebo effect. Possible methods of prevention and treatment of PFS are proposed.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Fernanda MONTORIL OLIVEIRA 医师

医师

巴西

其他作者 :

The Use of Poly-L-Lactic Acid and the Enhancement of Its Effects through Intramuscular Proline, L-Lysine, D-Panthenol, and Biotin

Objectives: The objective of this study is to evaluate the importance of supplementation during the use of biostimulatory agents. Specifically, this research aims to demonstrate how a four-week intramuscular supplementation regimen, administered once a week, can enhance the efficacy of biostimulators by ensuring effective nutrient absorption, ultimately optimizing the desired aesthetic outcomes.

Introduction: Skin aging and the loss of elasticity are complex processes involving a reduction in collagen and elastin production, leading to skin laxity and altered body contours. Poly-L-lactic acid (PLLA) has gained prominence in aesthetic dermatology as an effective bio-stimulator in promoting neocollagenesis. However, the quest for enhanced results has led to the investigation of combined approaches, such as the use of intramuscular supplements that may potentiate the effects of PLLA.

Materials / method: This literature review is based on an analysis of scientific articles, clinical studies, and systematic reviews published in major medical databases. The inclusion criteria were studies addressing the use of PLLA in body treatments, as well as research on the impact of intramuscular administration of L-Proline, L-Lysine, D-Panthenol, and Biotin on collagen synthesis and aesthetic outcomes.

Results: The intramuscular administration of L-Proline, L-Lysine, D-Panthenol, and Biotin may work synergistically with PLLA, enhancing its effects by providing the necessary substrates for collagen synthesis and stabilization. Preliminary studies suggest that combining these substances may accelerate the regenerative response and optimize aesthetic outcomes, especially in patients with low response to PLLA treatment alone. Additionally, the use of aminoacids such as L-Proline and L-Lysine can help maintain the integrity of newly formed collagen fibers, while D-Panthenol and Biotin can improve skin hi

Conclusion: The combination of poly-L-lactic acid with intramuscular administration of L-Proline, L-Lysine, D-Panthenol, and Biotin represents a promising approach to enhance aesthetic outcomes in body laxity treatments. Further clinical studies are needed to confirm the efficacy of this strategy and to establish application protocols that maximize benefits for patients

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Alfredo MARTINEZ 医师

博士研究员

西班牙

其他作者 :

The future of HA fillers: innovative delivery system beyond cross-linking

Objectives: The aim of this research is to develop a new HA cross-linked filler capable of containing key active ingredients which are released sustainably as the filler is degraded with time in order to increase its bio-stimulating effect. This new kind of delivery system would allow not only the treatment of facial imperfection by replacing the volume loss, but also the target of other tissular and cellular structures providing a more comprehensive result

Introduction: Dermal fillers are a key tool in medical aesthetic treatments to increase skin volume, reshape structures and reduce wrinkles. Hyaluronic acid is one of the most used fillers based on its safety profile compared to other biomaterials. The method for crosslinking fillers is a key step, it is highly controlled by specific parameters, and determines the durability and the rheological characteristics of the final product which in turn define the final clinical indication

Materials / method: We developed a unique crosslinked method which allows HA to maintain a reservoir of ingredients like succinic acid (SA). Cross-linked HA was incubated with hyaluronidase with/without SA to study changes in the viscoelastic properties (G’). Growth factors secretion in fibroblasts was quantified by antibody array. Gene expression was analysed by qPCR and mitophagy by fluorescence microscopy in senescent cells. Sustained release was studied in Franz cells and skin explants using a fluorochrome-loaded filler. SEM microscopy was performed to assess filler microstructure

Results: Results
SA inhibited hyaluronidase degradation of the cross-linked HA filler. SA increased the levels of regenerative growth factors and reduced senescence by decreasing IL-6, IL-8 and CXCL10. SA induced LOXL1, involved in elastic fibres maintenance, and PGC1α, involved in mitochondria biogenesis. SA also induced selective autophagy of mitochondria (mitophagy) in senescent fibroblasts. The release experiment evidenced that this product acts as a sustained release platform for skin volume that can incorporate different active ingredients to boost bio-stimulatory effects of the dermal filler.

Conclusion: Our research proves that SA acts both on healthy and senescent dermal fibroblasts, activating cellular responses that induce skin regeneration, rejuvenation and repair. Besides, the inhibitory effect of SA on hyaluronidase delays the degradation of the filler and thus increases its duration in the skin. This type of filler can be loaded with other active ingredients that are embedded throughout the matrix, and depending on the crosslinking applied, allow the release of these active ingredients over time.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
是
请注明名称（个人，公司，学会等等）: mesoestetic Pharma Group

您是否接受过关于这项研究的任何酬金或其他报酬？
是
请注明名称（个人，公司，学会等等）: mesoestetic Pharma Group

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作的完成感谢以下机构的支持： mesoestetic Pharma Group

Juliah Ahmad TBARANI 医师

美容整型外科医师

爱尔兰

其他作者 :

Non surgical Rhinoplasties - Is cannula safer than needle?

Objectives: 1) Understanding each individual nasal morphology
2) Plan and perform the best and safest treatment approach
3) Devastating complications like blindness are avoidable with appropriate treatment choices.
The mantra of "Knowing The Best Tools" over "The Tool You Know Best" is fundamental in driving superior and safer outcomes in non-surgical rhinoplasties

Introduction: Non-surgical rhinoplasties may seem like a quick and simple solution with hardly any downtime. There are two well-known non-surgical treatments for nose reshaping either with hyaluronic acid filler or with absorbable threads like PDO and a combination of both. Tailoring the treatment to each individual's unique nasal structure is crucial. Having worked with both Caucasian and Asian/ethnic patients, I've learned that the best outcomes require a deep understanding of techniques and nasal anatomy. While HA filler is common and cannula is deemed safer, it may not always be the best choice.

Materials / method: Outlining various case studies focusing on the use of HA filler, needles, threads, and cannula to address nasal structures, and skin morphology, and meet patients' expectations. Utilizing high G-Prime HA, PDO threads, Size 25G cannula, and sharp needles. Implementing multiple punctures with sharp needles, or 1 or 2 entry points approaches using the cannula for painless thread insertion.

Results: Utilizing PDO threads in ethnic nose cases, sometimes in conjunction with HA filler, has consistently produced excellent results without complications. Ethnic noses present challenges due to tight spaces between bones and skin and varying skin thickness. The use of solid materials like threads helps create a more stable foundation, effectively lifting the skin and enhancing the nasal septum compared to HA fillers.
There will be case studies showing the usage of HA, Threads, and combinations of both in different cases to outline appropriate approaches for best outcomes.

Conclusion: Practically and technically, having a universal tool is crucial for achieving safer, satisfactory, and favorable outcomes. Proficiency in using HA filler, threads, or a combination of both is essential. It's important to differentiate between having the "best" tools and being skilled with the tools you "know best.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Jyoti ANEJA 医师

皮肤科医师

印度

其他作者 :

The Sherlockian Approach to Neck Rejuvenation in the Regenerative Aesthetics Era

Objectives: To evaluate the effectiveness of bio-enhancers combined with other aesthetic treatments in achieving harmonious and youthful neck aesthetics. This approach emphasizes personalized treatment strategies that cater to individual anatomical characteristics and aesthetic goals.

Introduction: In the dynamic field of aesthetic medicine, the neck region presents unique challenges for achieving natural and lasting rejuvenation. The quest to enhance the neck's appearance has led to the development and integration of various regenerative techniques. This presentation explores a "Sherlockian" approach—meticulous, investigative, and adaptive—focusing on optimizing treatment modalities for neck rejuvenation.

Materials / method: Bio-Enhancers: Injectable treatments rich in HA that stimulate collagen & elastin production, improving skin texture & firmness without volumization. Typically, 2-3 treatments spaced 4 weeks apart are required.
Multi-Modal Techniques: Combining bio-enhancers with other treatments such as microneedling, botulinum toxin, fractional lasers, skin boosters & dermal fillers to achieve superior results.
Holistic Rejuvenation: Addressing changes in skin texture, muscle tone, and fat volume with a combination of minimally invasive procedures to ensure a comprehensive and natural-looking outcome

Results: My approach highlights the benefits of integrating bio-enhancers with other rejuvenation techniques. Patients showed significant improvement in skin texture and firmness, with enhanced overall neck contour. The treatments provided satisfactory results in managing age-related changes such as skin laxity, visible creases, and muscle hypertonicity.
Selecting appropriate candidates for neck rejuvenation involves considering factors like desired results, treatment frequency, recovery time, budget, and practitioner expertise. The personalized approach aligns with the "less is more" philosophy.

Conclusion: The regenerative aesthetics era offers promising advancements in neck rejuvenation. By adopting a Sherlockian approach—characterized by careful analysis and innovative technique adaptation—practitioners can achieve enduring and natural neck aesthetics. This paradigm shift towards personalized, less invasive treatments positions bio-enhancers as a key component in the future of aesthetic medicine, ensuring that the neck's timeless beauty is preserved and enhanced.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Raul ANTUNEZ CONDE HIDALGO 医师

颈面部整形外科医师

西班牙

其他作者 : Raúl Antúnez-Conde Hidalgo, José Luis Silva Canal

OROFACIAL AESTHETICS IN THE ONCOLOGIC PATIENT: A PROSPECTIVE STUDY FOR RECONSTRUCTION AND PROSTHETIC REHABILITATION

Objectives: To explain the possibilities of orofacial reconstruction in oncological patients by means of anatomical and functional reconstruction through the use of dental implants in microsurgical flaps and early prosthetic loading.

Introduction: The aim of this study is to evaluate the efficacy of orofacial reconstruction and prosthetic rehabilitation in oncologic patients with intraoral defects reconstructed using microsurgical flaps and dental implants, comparing those who received early prosthetic loading and deferred prosthetic loading.

Materials / method: A prospective clinical study was performed involving patients with a history of oral cavity cancer reconstructed with microsurgical flap and dental implants.
The control group received delayed prosthetic loading, while the test group received early loading. All implants were clinically tested, ISQ value was measured and radiographic control was performed at 0, 6 and 12 months for measurement of crestal bone resorption. QLQ-C30, QLQ-H&N35 and QLQ-H&N35 questionnaires were applied to assess esthetics-related quality of life.

Results: Twenty-five patients were included to date. The main diagnosis was squamous cell carcinoma (84.61%). The median global health status score was 79.27. The most prominent symptomatic item was dental problems (53.33), social eating problems (41.15) and oral openness (31.62).
A total of 108 dental implants were included in the study. The mean initial ISQ values were 74.4 ± 8.4. More than 82% of the implants showed values higher than 70 ISQ and the esthetic results perceived by the patients were excellent (78%) and good (22%).

Conclusion: Head and neck oncology patients can benefit from esthetic and functional rehabilitation using microsurgical flaps and implant rehabilitation with early loading.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Rebecca Susanna DEGLIUOMINI 医师

医师

意大利

其他作者 : Giovanni Buzzaccarini, Laura De Rosa, Silvia Villa, Gabriele Siesto, Stefano Salvatore, Massimo Candiani

Botulinum Toxin and Radiofrequency for the Treatment of Vaginismus and Dyspareunia: A Combined Protocol

Objectives: This protocol aims to explore the use of botulinum toxin (BTX) injections and radiofrequency (RF) treatment as a combined approach to alleviate pain during intercourse (dyspareunia) in patients suffering from vulvodynia. By integrating these two treatments, we aim to enhance tissue elasticity and reduce muscular tension, improving sexual health and quality of life for affected individuals.

Introduction: Vulvodynia and dyspareunia are conditions that significantly affect sexual well-being, often linked to hypertonicity in the pelvic floor muscles. Botulinum toxin, known for its ability to reduce muscle contractions by inhibiting acetylcholine release at the neuromuscular junction, has been investigated as a potential treatment for dyspareunia. The injection of BTX into the levator ani muscle, which plays a critical role in pelvic floor function, can reduce muscle spasm and alleviate pain. In parallel, radiofrequency therapy can be used in promoting tissue regeneration and vaginal elasticity.

Materials / method: This protocol involves the administration of botulinum toxin directly into the levator ani muscle to address excessive muscle tension. Specifically, 100 units (UI) of botulinum toxin are injected using a fine needle across multiple points in the muscle. In combination, radiofrequency treatment is applied to the vaginal and vulvar tissues to stimulate collagen production, improve tissue elasticity, and promote healing of microtears that can occur during intercourse. The combination of muscle relaxation from BTX and the regenerative effects of RF is intended to provide a dual therapeutic benefit

Results: In clinical applications, 100 UI of botulinum toxin are distributed across several injection points in the levator ani muscle, with the goal of reducing muscle hyperactivity and alleviating pain during intercourse. The radiofrequency treatment further contributes to improved tissue elasticity, which can help reduce post-coital tearing and discomfort. Our preliminary results suggest that this combined approach leads to a significant improvement in dyspareunia and overall sexual function.

Conclusion: The combination of botulinum toxin injections into the levator ani and radiofrequency therapy represents a promising approach to managing vulvodynia and dyspareunia. By targeting both muscle hypertonicity and tissue elasticity, this protocol addresses the primary physical factors contributing to pain during intercourse. Further studies are necessary to validate long-term outcomes and optimize treatment protocols, but the initial results are encouraging for the improvement of sexual health and well-being.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

您有问题要问？

在我们的常见问题解答中快速找到答案

大会

英卡思亚洲年会
英卡思中国大会
英卡思巴黎国际年会

关于我们

公司
隐私政策
法律信息

学院

主页
课程
Webinars
探索
博客

支援

教育援助

保持联系

联系我们

登录名/电邮地址

密码

保持登录状态

密码遗失 ? 还没有账号？现在注册

保持登录状态

academy.Do_not_have_an_account_yet 现在注册

2025 英卡思巴黎国际年会 大会日程

Open Stage - Non-sponsored scientific lectures

本场演讲内容

推荐会议

2025 英卡思巴黎国际年会
大会日程

本场演讲内容